| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/13/2003 | EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/13/2003 | EP0804252B1 Monoamine, diamide, thiol-containing metal chelating agents |
| 08/13/2003 | EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 08/13/2003 | EP0531472B1 Humanized monoclonal antibodies |
| 08/13/2003 | CN1436195A Integrin binding peptide derivatives |
| 08/13/2003 | CN1435419A Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof |
| 08/12/2003 | US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent |
| 08/12/2003 | US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/07/2003 | WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/07/2003 | WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens |
| 08/07/2003 | WO2002096948A3 Engineered tetravalent antibodies and methods of use |
| 08/07/2003 | US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149024 For therapy of central nervous system disorders such as diseases and conditions related to sleeping, eating, perceiving pain, controlling body temperature, controlling blood pressure, depression, anxiety, schizophrenia |
| 08/07/2003 | US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors |
| 08/07/2003 | US20030148347 Nuclear protein |
| 08/07/2003 | US20030147807 Water soluble paclitaxel derivatives |
| 08/07/2003 | CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/06/2003 | EP1332227A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 08/06/2003 | EP1332138A1 Radiopharmaceuticals for diagnosing alzheimer's disease |
| 08/05/2003 | US6603127 Generator capable of producing therapeutic Bismuth-213 doses. Also disclosed are methods of preparing Bismuth-213-labeled compounds using such generator and applications of the labeled compounds. |
| 08/05/2003 | US6602989 Protein conjugate gallium (III) complex comprising the reaction product of heterocyclylazoorthohydroxyarylene derivative and a protein; used for detection of gallium in biological samples |
| 08/05/2003 | US6602715 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 08/05/2003 | US6602524 Microspheres for use in the treatment of cancer |
| 08/05/2003 | US6602488 Labeling of diseased or malfunctioning candidate cells for subsequent treatment; in situ gene therapy |
| 08/05/2003 | CA2329259C Convection-enhanced delivery of aav vectors |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003061593A2 Novel targeted compositions for diagnostic and therapeutic use |
| 07/31/2003 | WO2003061577A2 Polyalkylene glycol with moiety for conjugating biologically active compound |
| 07/31/2003 | WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma |
| 07/31/2003 | WO2001097855A3 Targeted combination immunotherapy of cancer and infectious diseases |
| 07/31/2003 | US20030144570 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 07/31/2003 | US20030144474 T cell receptor and a biologically active polypeptide with different recognition biding sites connected by a peptide linker; designed to redirect the immune system against various diseases |
| 07/31/2003 | US20030144322 Analogs of cocaine |
| 07/31/2003 | US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 07/31/2003 | US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants |
| 07/31/2003 | US20030144266 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/31/2003 | US20030144198 Increasing gastrointestinal absorption |
| 07/31/2003 | US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis |
| 07/31/2003 | US20030143162 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 07/31/2003 | US20030143157 Method of treating tumors |
| 07/31/2003 | CA2840490A1 Polyalkylene glycol with moiety for conjugating biologically active compounds |
| 07/31/2003 | CA2753899A1 Polyalkylene glycol with moiety for conjugating biologically active compounds |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2473748A1 Novel targeted compositions for diagnostic and therapeutic use |
| 07/30/2003 | EP1331479A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like |
| 07/30/2003 | EP1330268A1 Targeted therapeutic agents |
| 07/30/2003 | EP0831936B1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 07/30/2003 | CN1433326A Method for determining viability of myocardial segment |
| 07/29/2003 | US6599750 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 07/29/2003 | US6599275 Device comprising first and second tubes of base material, one within the other, containing plurality of treatment materials having different diffusion rates distributed or positioned so they diffuse simultaneously to surface of permeable tube |
| 07/29/2003 | CA2134092C Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 07/29/2003 | CA2089070C Cocaine receptor binding ligands |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059397A2 Labeling targeting agents with gallium-68 and gallium-67 |
| 07/24/2003 | WO2003059153A2 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | US20030139661 Ingestible device |
| 07/24/2003 | US20030138375 Individualization of therapy with Alzheimer's disease agents |
| 07/24/2003 | US20030138374 A radioactive labeled compounds for diagnosing Alzheimer's disease |
| 07/24/2003 | CA2474138A1 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 07/24/2003 | CA2471817A1 Labeling targeting agents with gallium-68 and gallium-67 |
| 07/24/2003 | CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/23/2003 | EP1328635A2 Compositions and methods relating to lung specific genes |
| 07/23/2003 | EP1328320A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 07/22/2003 | US6596206 Generation of pharmaceutical agent particles using focused acoustic energy |
| 07/22/2003 | CA2083041C Labeled compounds for use in a diagnostic breath test |
| 07/17/2003 | WO2003057837A2 Methods for using anti-muc18 antibodies |
| 07/17/2003 | WO2003057250A1 Cancer treatment |
| 07/17/2003 | WO2003057160A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | WO2003057155A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | WO2003057006A2 Use of antibodies against the muc18 antigen |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | US20030134793 Water soluble compositions of paclitaxel and docetaxel formed by conjugating the paclitaxel or docetaxel to a water soluble polymer such as poly-glutamic acid, poly- aspartic acid or -lysine. Methods of using the compositions for treatment of |
| 07/17/2003 | US20030133972 Macromolecules of 3-(4-(2-(3,4,5,6-tetrahydropyrimidin-2-ylamino)-ethyloxy)-benzoylamino)-2(S)-benzene-sulfonyl -aminopropionic acid moiety |
| 07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
| 07/17/2003 | US20030133872 Radiopharmaceutical agent for the treatment of early stage cancer |
| 07/17/2003 | CA2472893A1 Cancer treatment |
| 07/17/2003 | CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | CA2472154A1 Use of antibodies against the muc18 antigen |
| 07/17/2003 | CA2471936A1 Methods for using anti-muc18 antibodies |
| 07/17/2003 | CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 07/16/2003 | EP1326531A2 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| 07/16/2003 | EP1220691A4 Methods and apparatus for characterizing lesions in blood vessels and other body lumens |
| 07/16/2003 | EP1210353B1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 07/16/2003 | EP1191947A4 Methods for treating avm' using radioactive compositions |
| 07/16/2003 | EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use |
| 07/16/2003 | EP0781145B1 Diagnostic compositions and their use for the detection of central nervous system abnormalities |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592843 Liposome mixture containing chelator solution and alpha particle emitting radionuclides; cancer therapy |
| 07/10/2003 | WO2003055935A1 Dendritic poly (amino acid) carriers and methods of use |
| 07/10/2003 | WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | WO2003055379A2 Method using a surface-selective nonlinear optical technique for imaging of biological samples |
| 07/10/2003 | WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
| 07/10/2003 | US20030130341 Taxoids formed by conjugating paclitaxel/docetaxel to polyglutamic acid, polyaspartic acid, or polylysine; antitumor agents; treatment of rheumatoid arthritis and autoimmune diseases |
| 07/10/2003 | US20030130336 Single photon emission computed tomography brain imaging to predict the activity of antidepressants or anxiolytic agents on striatal dopamine transporter populations; marker for predicting sexual dysfunction side effects; dosage |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |